ATE380190T1 - Verbessertes verfahren zur herstellung von 5,6 - dihydro -4h-4(s)-ethylamin-6(s)-methylthieno(2,3- b) thiopyran-2-sulfonamid- 7,7 -dioxid und seinen salzen - Google Patents

Verbessertes verfahren zur herstellung von 5,6 - dihydro -4h-4(s)-ethylamin-6(s)-methylthieno(2,3- b) thiopyran-2-sulfonamid- 7,7 -dioxid und seinen salzen

Info

Publication number
ATE380190T1
ATE380190T1 AT05816357T AT05816357T ATE380190T1 AT E380190 T1 ATE380190 T1 AT E380190T1 AT 05816357 T AT05816357 T AT 05816357T AT 05816357 T AT05816357 T AT 05816357T AT E380190 T1 ATE380190 T1 AT E380190T1
Authority
AT
Austria
Prior art keywords
methylthieno
thiopyran
sulfonamide
dihydro
dioxide
Prior art date
Application number
AT05816357T
Other languages
English (en)
Inventor
Anand Chandavarkar
Rajaram Bapat
Anand Bade
Anand Chavan
Original Assignee
Fdc Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fdc Ltd filed Critical Fdc Ltd
Application granted granted Critical
Publication of ATE380190T1 publication Critical patent/ATE380190T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT05816357T 2004-07-09 2005-07-06 Verbessertes verfahren zur herstellung von 5,6 - dihydro -4h-4(s)-ethylamin-6(s)-methylthieno(2,3- b) thiopyran-2-sulfonamid- 7,7 -dioxid und seinen salzen ATE380190T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN741MU2004 2004-07-09

Publications (1)

Publication Number Publication Date
ATE380190T1 true ATE380190T1 (de) 2007-12-15

Family

ID=35645690

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05816357T ATE380190T1 (de) 2004-07-09 2005-07-06 Verbessertes verfahren zur herstellung von 5,6 - dihydro -4h-4(s)-ethylamin-6(s)-methylthieno(2,3- b) thiopyran-2-sulfonamid- 7,7 -dioxid und seinen salzen

Country Status (9)

Country Link
US (1) US8198316B2 (de)
EP (1) EP1765828B1 (de)
AT (1) ATE380190T1 (de)
AU (1) AU2005290855B2 (de)
CA (1) CA2570415C (de)
DE (1) DE602005003672T2 (de)
MX (1) MXPA06015274A (de)
WO (1) WO2006038222A1 (de)
ZA (1) ZA200609816B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006078731A2 (en) * 2005-01-18 2006-07-27 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Amorphous and crystalline forms of dorzolamide hydrochloride and processes of making same
ATE438649T1 (de) * 2006-04-21 2009-08-15 Zach System Spa Verfahren zur herstellung von dorzolamid

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797413A (en) * 1986-05-14 1989-01-10 Merck & Co., Inc. Thieno thiopyran sulfonamide derivatives, pharmaceutical compositions and use
US4677115A (en) * 1984-12-12 1987-06-30 Merck & Co., Inc. Antiglaucoma thieno-thiopyran and thieno-thiepin sulfonamide derivatives, compositions, and method of use thereof
US5011942A (en) * 1990-02-05 1991-04-30 Merck & Co., Inc. Process for racemizing an enantiomer of 5,6-dihydro-4-alkylamino-4H-thieno(or furo) [2,3-B]-thiopyran-2-sulfonamide-7,7-dioxide
US4968814A (en) * 1990-04-18 1990-11-06 Merck & Co., Inc. (S)-Alkyl 3-(thien-2-ylthio)butyrate and analogs and synthesis thereof
US5157129A (en) * 1990-04-18 1992-10-20 Merck & Co., Inc. Enantiospecific synthesis of s-(+)-5,6-dihydro-4-(r-amino)-4h-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide
TW265343B (de) * 1993-03-22 1995-12-11 Merck & Co Inc
US5441722A (en) * 1994-02-18 1995-08-15 Merck & Co., Inc. Short synthesis of 5,6-dihydro-(S)-4-(ethylamino)-(S)-6-[C3 H3 ]-4[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide and related non radioactive compounds
US5574176A (en) * 1995-04-26 1996-11-12 Merck & Co., Inc. Synthesis of an intermediate for the preparation of 5,6-dihydro-(s)-4-(ethylamino)-(s)-6-methyl-4h-thieno [2,3-b]thiopyran-2-sulfonamide 7,7-dioxide intermediates and related compounds
US5760249A (en) * 1995-08-29 1998-06-02 Merck & Co., Inc. Synthesis of hydroxysulfone and related compounds
ES2177415B1 (es) * 2000-09-04 2004-10-16 Ragactives, S.L. Procedimiento para la obtencion de 4-alquilamino-5, 6-dihidro-4h-tieno-(2,3b)-tiopiran-2-sulfonamida-7-dioxidos, e intermedios.

Also Published As

Publication number Publication date
AU2005290855B2 (en) 2010-08-19
WO2006038222A1 (en) 2006-04-13
EP1765828B1 (de) 2007-12-05
CA2570415C (en) 2012-04-17
ZA200609816B (en) 2008-08-27
US20090264662A1 (en) 2009-10-22
MXPA06015274A (es) 2007-09-27
EP1765828A1 (de) 2007-03-28
DE602005003672D1 (de) 2008-01-17
DE602005003672T2 (de) 2008-11-20
AU2005290855A1 (en) 2006-04-13
US8198316B2 (en) 2012-06-12
CA2570415A1 (en) 2006-04-13

Similar Documents

Publication Publication Date Title
HRP20050641A2 (en) New carboxylic acids and the esters thereof, pharmaceutical compositions containing these compounds and processes for the preparation thereof
DE60330800D1 (de) Verfahren zur herstellung von pyrrolotriazinverbindungen, die sich als kinaseinhibitoren eignen
NZ601326A (en) Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
ATE425136T1 (de) Verfahren zur herstellung substituierter 3-aryl- butyl-aminverbindungen
ATE430153T1 (de) Verfahren zur verminderung von alpha, beta- ungesättigten ketonen in opioidzusammensetzungen
ATE407111T1 (de) Isolierte atomoxetinverunreinigung, verfahren zur herstellung von atomoxetinverunreinigungen und deren verwendung als referenzstandards
WO2005051358A8 (en) Composition and method for enhancing bioavailability
ATE537136T1 (de) Neues verfahren zur herstellung von säurechloriden
ATE515496T1 (de) Verfahren zur herstellung von enantiomerenangereicherter indolin-2-carbonsäure
EA200700673A1 (ru) Твердая фармацевтическая композиция, содержащая донепезила гидрохлорид
ATE506352T1 (de) Verfahren zur herstellung von optional 2- substituierten 1,6-dihydro-6-oxo-4- pyrimidincarboxylsäuren
ATE319702T1 (de) Verfahren zur herstellung von benzothiophen- derivaten
ATE453622T1 (de) Verfahren zur herstellung von enantiomeren angereicherten cyclischen beta-aryl- oder heteroarylcarbonsäuren
DE602004020895D1 (de) Verfahren zur herstellung von kohlenstoffnanospulen
IL177286A0 (en) Albumin-purification method comprising a nanofiltration step, solution, and composition for therapeutic use containing same
ATE354583T1 (de) Verfahren zur herstellung c-7 substituierter 5- androstene
ATE514702T1 (de) Verfahren zur herstellung von clopidogrel und dabei verwendete zwischenprodukte
ATE380190T1 (de) Verbessertes verfahren zur herstellung von 5,6 - dihydro -4h-4(s)-ethylamin-6(s)-methylthieno(2,3- b) thiopyran-2-sulfonamid- 7,7 -dioxid und seinen salzen
EP1697257A4 (de) Verfahren zur herstellung von nanorohren aus hochreinem kohlenstoff unter verwendung von wasser
DE502005009501D1 (de) Verfahren zur herstellung von candesartan
ATE346061T1 (de) Verfahren zur herstellung von (s)-3-methylamino-1-(thien-2-yl)propan-1-ol
ATE424892T1 (de) Verfahren zur herstellung von derivaten des 4a,5, 9,10,11,12-hexahydrobenzofuro ä3a,3,2üä 2 ü- benzazepins
HUP0203812A2 (hu) Eljárás ciklusos aminosavak sztereoszelektív előállítására
DE60329305D1 (de) VERFAHREN ZUR HERSTELLUNG VON FLUORCARBONSuUREN
ATE472523T1 (de) Verbessertes verfahren zur herstellung von rivastigmin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties